Malignant Neoplasms of Urinary Tract: Clinical Trials

3 trials for Malignant Neoplasms of Urinary Tract, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 withdrawn. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 1, Recruiting 1, Withdrawn 1

Follow Malignant Neoplasms of Urinary Tract: new trials by email Literature Review of Malignant Neoplasms of Urinary Tract trials Research Report on Malignant Neoplasms of Urinary Tract

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
Pembrolizumab, Clostridium Novyi-NT, Doxycycline - Malignant Neoplasm of Breast, Malignant Neoplasms of Digestive Organs
Phase 1CompletedM.D. Anderson Cancer Center182018-07-102026-11-03
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Gemcitabine - Malignant Neoplasm of Bone and Articular Cartilage, Malignant Neoplasms of Female Genital Organs
Phase 1RecruitingM.D. Anderson Cancer Center442017-11-222026-11-10
Lenvatinib and Capecitabine in Patients With Advanced Malignancies
Lenvatinib, Capecitabine - Advanced Cancer, Malignant Neoplasm of Breast
Phase 1WithdrawnM.D. Anderson Cancer Center2016-12-012017-06-26

Narrower conditions

Urologic Neoplasms (3)  ·  Breast Neoplasms (2)  ·  Bone Neoplasms (1)  ·  Melanoma (1)  ·  Osteosarcoma (1)

Broader conditions

Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Male Urogenital Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Urogenital Diseases (3)  ·  Urogenital Neoplasms (3)  ·  Urologic Diseases (3)  ·  Breast Diseases (2)  ·  Bone Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Bone Tissue (1)

Interventions

Capecitabine (1)  ·  Doxycycline (1)  ·  Gemcitabine (1)  ·  lenvatinib (1)  ·  pembrolizumab (1)

Sponsors

M.D. Anderson Cancer Center (3)

Countries

United States (2)

Top investigators

David S. Hong, MD (1)  ·  Najat C. Daw-Bitar, MD (1)  ·  Sarina Piha-Paul, MD (1)  ·  Sarina Piha-Paul, MD, PHD (1)